188 related articles for article (PubMed ID: 26360373)
1. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.
Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H
J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373
[TBL] [Abstract][Full Text] [Related]
2. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
3. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
Mohad V; Lungova V; Verheyden J; Thibeault SL
Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma.
Zhao F; Yang Z; Chen Y; Zhou Q; Zhang J; Liu J; Wang B; He Q; Zhang L; Yu Y; Liu P
World Neurosurg; 2018 Sep; 117():e269-e279. PubMed ID: 29902598
[TBL] [Abstract][Full Text] [Related]
6. The Hippo pathway member Nf2 is required for inner cell mass specification.
Cockburn K; Biechele S; Garner J; Rossant J
Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728
[TBL] [Abstract][Full Text] [Related]
7. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
8. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation.
McNeill H; Reginensi A
J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853
[TBL] [Abstract][Full Text] [Related]
9. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS
Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of Motin family proteins in NF2-deficient cells prevents full activation of YAP/TAZ and rapid tumorigenesis.
Wang Y; Zhu Y; Gu Y; Ma M; Wang Y; Qi S; Zeng Y; Zhu R; Wang X; Yu P; Xu J; Shu Y; Yu FX
Cell Rep; 2021 Aug; 36(8):109596. PubMed ID: 34433060
[TBL] [Abstract][Full Text] [Related]
11. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
[TBL] [Abstract][Full Text] [Related]
12. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J
Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529
[TBL] [Abstract][Full Text] [Related]
13.
Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D
FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
15.
Li L; Dong L; Wang Y; Zhang X; Yan J
Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
[TBL] [Abstract][Full Text] [Related]
16. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells.
Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A
FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712
[TBL] [Abstract][Full Text] [Related]
17. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
[TBL] [Abstract][Full Text] [Related]
18. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
19. Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.
Boin A; Couvelard A; Couderc C; Brito I; Filipescu D; Kalamarides M; Bedossa P; De Koning L; Danelsky C; Dubois T; Hupé P; Louvard D; Lallemand D
Neuro Oncol; 2014 Sep; 16(9):1196-209. PubMed ID: 24558021
[TBL] [Abstract][Full Text] [Related]
20. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate.
Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]